Geneos Wealth Management Inc. Palatin Technologies Inc Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Sep 07, 2021	SELL	$0.78 - $1.09 $780 - $1,090	-1,000 Closed	0 $0
Q2 2019 Sep 07, 2021	SELL	$0.98 - $1.64 $4,900 - $8,200	-5,000 Reduced 83.33%	1,000 $1,000
Q1 2019 Sep 07, 2021	BUY	$0.67 - $1.01 $4,020 - $6,060	6,000 New	6,000 $5,000
Q2 2018 Sep 07, 2021	SELL	$0.91 - $1.45 $910 - $1,450	-1,000 Closed	0 $0
Q1 2018 Sep 07, 2021	BUY	$0.84 - $1.18 $840 - $1,180	1,000 New	1,000 $1,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $9.01M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.